Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis

BioMed Research International
Guomin YangQiulan Li

Abstract

Endogenous secretory receptor for advanced glycation end products (esRAGE) binds extracellular RAGE ligands and blocks RAGE activation on the cell surface, protecting endothelial cell function. However, the underlying mechanism remains unclear. Endothelial cells overexpressing the esRAGE gene were generated using a lentiviral vector. Then, quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) were used to assess esRAGE mRNA and protein levels, respectively. Hoechst-PI double staining was used to assess apoptosis. Western blot and qRT-PCR were used to assess the expression levels of apoptosis-related factors and the proinflammatory cytokine NF-кB. Compared with the control group, AGEs significantly induced endothelial cell apoptosis, which was significantly reduced by esRAGE overexpression. Incubation with AGEs upregulated the proapoptotic factor Bax and downregulated the antiapoptotic factor Bcl-2. Overexpression of esRAGE reduced Bax expression induced by AGEs and increased Bcl-2 levels. Furthermore, AGEs increased the expression levels of proinflammatory cytokine NF-кB, which were reduced after esRAGE overexpression. esRAGE protects endothelial cells from AGEs associated apop...Continue Reading

References

Oct 15, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Hidenori KoyamaYoshiki Nishizawa
Dec 20, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Barry I HudsonAnn Marie Schmidt
Jan 15, 2008·International Journal of Cardiology·K M ChoiS H Baik
Jul 8, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Angela RaucciMarco E Bianchi
Jul 22, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Lin LuWei Feng Shen
Jan 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li-Min LiKe Zen
Apr 2, 2011·Cell Death and Differentiation·H ZhangM Lai
Nov 9, 2011·Cardiovascular Research·Saran ShantikumarCostanza Emanueli
Jul 5, 2012·The Journal of Clinical Endocrinology and Metabolism·Natale VazzanaGiovanni Davì
Mar 21, 2013·International Journal of Biological Macromolecules·Ying LiXuebo Liu
Oct 3, 2013·International Journal of Molecular Sciences·Gurdip DaffuAnn Marie Schmidt
Oct 15, 2013·American Journal of Medical Genetics. Part a·M Michael Cohen
Mar 14, 2014·Redox Biology·Christiane OttAndreas Simm
May 20, 2014·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·X LinH Cai
Oct 4, 2014·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Xiao-Dan WuShi-Yuan Xu
Oct 6, 2014·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Saori MoriyaShinichiro Uchiyama
Sep 27, 2015·Cardiovascular Diabetology·Martin HeierKnut Dahl-Jørgensen
Feb 18, 2016·The Journal of Clinical Endocrinology and Metabolism·Antonino Di PinoAgata Maria Rabuazzo
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·J Yu, S Park

❮ Previous
Next ❯

Citations

Jul 12, 2019·Frontiers in Physiology·Chinedum EleazuMahaneem Mohamed

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
fluorescence microscopy

Software Mentioned

Image
Image Lab
Pro
SPSS
Plus

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis